Beverley Hargadon

Medicine · Health Sciences

36h-index11.4kcitations93works19.42yr avg
OpenAlex↗ORCID↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Asthma and respiratory diseases(51), Respiratory and Cough-Related Research(22), Chronic Obstructive Pulmonary Disease (COPD) Research(18), Long-Term Effects of COVID-19(16), COVID-19 Clinical Research Studies(13)

Publications70 total

The effects of inhaled corticosteroids on healthy airways
2024
The effects of inhaled corticosteroids on healthy airways
Allergy·2024· 12 citedOpen Access
Post-acute COVID-19 neuropsychiatric symptoms are not associated with ongoing nervous system injury
Brain Communications·2023· 11 citedOpen Access
Cohort Profile: Post-Hospitalisation COVID-19 (PHOSP-COVID) study
International Journal of Epidemiology·2023· 15 citedOpen Access
The effects of inhaled corticosteroids on healthy airways
2023· 2 citedOpen Access
Relative abundance of Haemophilus as a component of the respiratory microbiome is not associated with airway epithelial MUC5AC staining
2023
Visualization of exhaled breath metabolites reveals distinct diagnostic signatures for acute cardiorespiratory breathlessness
Science Translational Medicine·2022· 48 citedOpen Access
Airway remodelling rather than cellular infiltration characterizes both type2 cytokine biomarker‐high and ‐low severe asthma
Allergy·2022· 30 citedOpen Access
Diagnosis of COVID-19 by exhaled breath analysis using gas chromatography–mass spectrometry
ERJ Open Research·2021· 103 citedOpen Access
Volatile organic compounds in a headspace sampling system and asthmatics sputum samples
Journal of Breath Research·2020· 9 citedOpen Access
Composite type-2 biomarker strategy versus a symptom–risk-based algorithm to adjust corticosteroid dose in patients with severe asthma: a multicentre, single-blind, parallel group, randomised controlled trial
The Lancet Respiratory Medicine·2020· 130 citedOpen Access
A Feasibility Study of a Randomized Controlled Trial of Asthma-Tailored Pulmonary Rehabilitation Compared with Usual Care in Adults with Severe Asthma
The Journal of Allergy and Clinical Immunology In Practice·2020· 26 cited
Severe exacerbations in moderate-to-severe asthmatics are associated with increased pro-inflammatory and type 1 mediators in sputum and serum
BMC Pulmonary Medicine·2019· 43 citedOpen Access
Corrigendum to: Cohort profile: Extended Cohort for E-health, Environment and DNA (EXCEED)
International Journal of Epidemiology·2019· 11 citedOpen Access
Lung Computational Models and the Role of the Small Airways in Asthma
American Journal of Respiratory and Critical Care Medicine·2019· 127 citedOpen Access
Assessment of breath volatile organic compounds in acute cardiorespiratory breathlessness: a protocol describing a prospective real-world observational study
BMJ Open·2019· 38 citedOpen Access
Cohort Profile: Extended Cohort for E-health, Environment and DNA (EXCEED)
International Journal of Epidemiology·2019· 20 citedOpen Access
Exacerbations of severe asthma in patients treated with mepolizumab
European Respiratory Journal·2018· 23 citedOpen Access
Cohort Profile: Extended Cohort for E-health, Environment and DNA (EXCEED)
2018· 3 citedOpen Access
Airway pathological heterogeneity in asthma: Visualization of disease microclusters using topological data analysis
Journal of Allergy and Clinical Immunology·2018· 36 citedOpen Access
page 1 of 4Next →

Frequent Co-authors

Christopher E. Brightling(41), Peter Bradding(26), Ian Pavord(26), Andrew J. Wardlaw(21), Salman Siddiqui(14), Amisha Singapuri(13), David F. Choy(10), Liam G. Heaney(10), Joseph R. Arron(10), Ruth H. Green(9), Louise V. Wain(9), William Monteiro(8), Aarti Shikotra(8), Matthew Richardson(8), Pranabashis Haldar(7), Joshua Agbetile(7), Michelle Bourne(7), Neil Greening(7), Susan McKenna(6), M. Shelley(6)